Department of Respiratory and Critical Care Medicine, Second Xiangya Hospital, Central South University, Changsha 410011, China.
Zhong Nan Da Xue Xue Bao Yi Xue Ban. 2023 Mar 28;48(3):330-338. doi: 10.11817/j.issn.1672-7347.2023.220309.
Diffuse panbronchiolitis (DPB) is a chronic airway inflammation with low specificity and its diagnosis is often missed or delayed. This study aims to summarize the clinical characteristics and treatment of DPB in order to improve the understanding and diagnosis of the disease.
The clinical data of 32 DPB patients were collected, analyzed and summarized from March 1, 2013 to March 1, 2022 in the Second Xiangya Hospital of Central South University. The basic information, clinical manifestations, laboratory tests, pulmonary function, imaging tests, treatment, and regression of patients were analyzed.
A total of 32 patients were enrolled in the final analysis, with a male-to-female ratio at 1.67. The median age at symptom onset was 26.5 (11.0-69.0) years, and the median age of diagnosis was 47.5 (16.0-77.0) years. All patients presented with chronic cough and copious sputum production. A total of 26 patients had post activity shortness of breath and 14 patients had a positive result (blood cold agglutination test titer≥1꞉64). Pulmonary function examination was performed in 31 patients, 18 patients showed mixed pulmonary ventilation dysfunction, 12 patients showed obstructive pulmonary ventilation, and 1 patient had normal pulmonary ventilation function. A total of 31 patients had a bilateral, diffuse, small nodule pattern on chest CT. All patients were treated with macrolides. A total of 31 patients showed improvement, and 20 patients showed improvement in partial pressure of oxygen and blood oxygen saturation compared with before at discharge. A total of 12 patients were re-examined by chest CT after completing macrolides treatment, 6 cases showed less diffuse nodules, 5 cases showed no significant changes, and 1 case showed more diffuse nodules, which indicated the disease progression. Seven patients received pulmonary function tests after completing macrolides treatment, forced expiratory volume in one second (FEV) and FEV/forced vital capacitywere improved, but forced expiratory flow at 25% of vital capacity did not change significantly.
The clinical manifestations of DPB are nonspecific. Early diagnosis and treatment are very important for the prognosis of patients.
弥漫性泛细支气管炎(DPB)是一种慢性气道炎症,特异性低,诊断常被延误或漏诊。本研究旨在总结 DPB 的临床特征和治疗方法,以提高对该病的认识和诊断。
收集 2013 年 3 月 1 日至 2022 年 3 月 1 日中南大学湘雅二医院收治的 32 例 DPB 患者的临床资料,进行回顾性分析。分析患者的基本信息、临床表现、实验室检查、肺功能、影像学检查、治疗及转归。
最终纳入 32 例患者,男女性别比为 1.67:1。中位发病年龄 26.5(11.0-69.0)岁,中位确诊年龄 47.5(16.0-77.0)岁。所有患者均表现为慢性咳嗽、大量咳痰。26 例患者活动后气促,14 例血冷凝集试验滴度阳性(≥1꞉64)。31 例患者行肺功能检查,18 例为混合性通气功能障碍,12 例为阻塞性通气功能障碍,1 例为正常通气功能。31 例患者胸部 CT 表现为双肺弥漫性、小结节样改变。所有患者均予大环内酯类药物治疗。31 例患者病情改善,出院时与治疗前相比,20 例患者的血氧分压和血氧饱和度均有改善。12 例患者完成大环内酯类药物治疗后复查胸部 CT,6 例结节较前减少,5 例无明显变化,1 例结节较前增多,提示疾病进展。7 例患者完成大环内酯类药物治疗后复查肺功能,用力肺活量(FEV)、FEV/用力肺活量较前改善,但 25%肺活量时的呼气流量改善不明显。
DPB 的临床表现无特异性,早期诊断和治疗对患者的预后非常重要。